New Key Statistics Module, Z-Score and F-Score
NAS:CRVS Key Ratios
Market Cap $ M | 292.37 |
Enterprise Value $ M | 279.99 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 24.75 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.92 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 23.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -11.16 |
EV-to-EBITDA | -11.20 |
PEG | -- |
Shares Outstanding M | 64.26 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 0.92 |
Current Ratio | 0.92 |
ROA % (ttm) | -108.89 |
ROE % (ttm) | -157.89 |
ROIC % (ttm) | -88.11 |
Dividend Yield % | -- |
Altman Z-Score | -- |
CRVS Number of Guru Trades
CRVS Volume of Guru Trades
Gurus Latest Trades with NAS:CRVS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CRVS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Corvus Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:CRVS
Total 0- 1